InSimili
Maila Becconi is a Technology Transfer Project Manager at Thermo Fisher Scientific and a Co-Founder and Chief Technology Officer at InSimili. Prior to these roles, Maila worked as a Tutor didattico at Alma Mater Studiorum - Università di Bologna. Maila holds a PhD in Nanoscience for Medicine and the Environment from Alma Mater Studiorum – Università di Bologna, along with a Master of Business Administration (MBA) from Bologna Business School and a Bachelor's degree in chemistry from the same university. Additionally, Maila completed an Erasmus+ study period at Karl-Franzens-Universität Graz.
This person is not in the org chart
This person is not in any teams
InSimili
InSimili s.r.l. is a private biotechnology company that aims to bring to the market a patented technology, which will revolutionize the drug selection process. Our product is able to recreate, in the laboratory experiments, several pathological and physiological conditions of human tissues. This feature enables in vitro drug testing in an environment which is much closer to the one of human tissues, where the drug has to effectively work. This approach will enable a better evaluation of the real efficacy of pharmacological treatments, limiting the number of drugs wrongly selected in the preclinical phase and, as a consequence, reducing the failures in the clinical phases. This approach will make the drug selection process faster, more efficient and more safe in respect to the actually adopted procedures.